ABT GLOBAL LLC (DEF) Awarded $83,824,802 Federal Contract by Department of Health and Human Services
ABT GLOBAL LLC (DEF) Awarded $83,824,802 Federal Contract by Department of Health and Human Services
On 2026-09-01, the Department of Health and Human Services formally obligated a federal contract action valued at $83,824,801.82 to ABT GLOBAL LLC (ticker DEF) under award identifier CONT_AWD_75D30120C08150_7523_-NONE-_-NONE-. Contract scope: COVID-19 RESEARCH IN REPONSE TO BAA POSTING. This obligation falls within the defense and federal procurement category and is recorded in official U.S. federal spending disclosures; the full transaction record, modification history, and any sub-award breakdown can be independently verified on USAspending.gov under award CONT_AWD_75D30120C08150_7523_-NONE-_-NONE-. For capital-intelligence context, watch whether members of congressional oversight committees hold or trade DEF positions around this award window.
Verified Quantitative Data
| Metric | Value |
|---|---|
| Amount | $83.82M |
Full trading intelligence, federal contract history and congressional flow for DEF.
Primary Source Record
This fact is compiled from public federal disclosure records. Explore the underlying dataset on the Federal Contract Explorer and the Capitol Trades leaderboard.
Cite This Data
APA: Gemral Edge Intelligence. (2026). ABT GLOBAL LLC (DEF) Awarded $83,824,802 Federal Contract by Department of Health and Human Services. Gemral Research Repository. https://gemral.com/edge/q/abt-global-llc-def-department-of-health-and-human-services-award-83824802-2026-09-01
@misc{abt-global-llc-def-department-of-health-and-human-services-award-83824802-2026-09-01,
author = {Gemral Edge Research Intelligence},
title = {ABT GLOBAL LLC (DEF) Awarded $83,824,802 Federal Contract by Department of Health and Human Services},
howpublished = {\url{https://gemral.com/edge/q/abt-global-llc-def-department-of-health-and-human-services-award-83824802-2026-09-01}},
year = {2026},
note = {Provenance Hash: 6d7df439765cb3a5}
}Data intelligence from public filings — not investment advice.